LYB - Educational Analysis * US Equities
Educational Analysis * US Equities

LYB

Earnings behavior, post-earnings drift, and the gap between consensus and the market's real expectation - the educational primer before you look at the institutional verdict.

Educational content only - not investment advice. Nothing on this page is a recommendation to buy or sell any security. Historical patterns do not predict future outcomes. Consult a licensed financial advisor before making any trading decision.
Published byGamma QC editorial
TickerLYB
CategoryEducational primer
Last reviewedSeptember 7, 2026
You're viewing an older edition of this page.Read the latest edition →

Business profile & competitive position

LyondellBasell Industries N.V. operates in the Basic Materials sector under the Chemicals – Specialty classification, with a global footprint across the petrochemical value chain. The company converts liquid and gaseous hydrocarbon feedstocks into plastic resins and other chemicals, develops and licenses chemical and polyolefin process technologies, and manufactures polyolefin catalysts. Its operations are organized into five reportable segments: Olefins and Polyolefins–Americas; Olefins and Polyolefins–Europe, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; and Technology. That diversity means LYB is not just a commodity plastics producer; it also collects technology licensing revenue and specialized polymer sales, which can carry margin profiles distinct from bulk olefins.

What stands out in the financial record, however, is a net margin of -1.1% and an ROE of -3.4%. Those negative figures are unusual for a company that historically benefits from scale and cost-advantaged North American feedstock access. A negative margin/ROE combination suggests the current earnings power of the asset base is under pressure, and that whatever moat may exist from technology licensing or integrated refining-to-chemicals logistics is not, at this moment, translating into positive returns. Analysts typically interpret a negative ROE as a signal that reinvestment is not earning its cost of capital; for a capital-heavy chemical operator, that points more to a cyclical trough than a permanently impaired franchise. The business model remains asset-intensive and feedstock-linked, so competitive advantage is likely to reassert itself through cost position and utilization rather than pricing power alone.

Financial posture

LYB currently carries a market capitalization of $20.5 billion and trades at a negative P/E of -56.7, which mechanically reflects the lack of trailing net income rather than a meaningful valuation premium or discount on its own. The net margin of -1.1% and ROE of -3.4%, taken together, describe a company running below break-even on the bottom line despite its size. The stock’s beta is 0.35, unusually low for the materials space; that low reading tells a trader that LYB has been moving far less dramatically than the broad market, potentially because its shares are already discounting a weak earnings cycle and because chemical cash flows are being weighed against asset-sale proceeds and restructuring activity.

In practical terms, a negative P/E is not a valuation signal by itself—it is a reminder that earnings are currently negative and that the market is instead valuing LYB off of cash flow, asset value, or recovery expectations. The $20.5 billion market cap is the market’s aggregate judgment of the enterprise net of those considerations. Traders watching LYB should treat the balance sheet and capital-allocation story as at least as important as the earnings multiple, because headline P/E is distorted by the current trough.

Strategic priorities & outlook

According to LyondellBasell’s most recent 10-K filing, management has framed its near-term agenda around four priorities. The first is to grow and upgrade the core business by reshaping the portfolio to support growth, increase resiliency, and drive higher returns in advantaged feedstock markets. This reflects an explicit effort to exit or reposition assets where the cost position is weaker.

The second priority is to build a profitable Circular & Low Carbon Solutions business that sources recycled and renewable feedstocks and leverages existing technology and assets for sustainable materials at scale. A concrete piece of that strategy is the MoReTec-1 chemical recycling plant in Wesseling, Germany, which broke ground in 2024 and is designed for 50 thousand metric tons per year of capacity. Third, the company is focused on stepping up performance and culture, including a transformation of Advanced Polymer Solutions, aimed at continuous value creation rather than simply cutting costs. Finally, execution is meant to be supported by the Value Enhancement Program, strong cash generation, disciplined capital allocation, and maintaining an investment-grade balance sheet.

Two operational facts from the filing stand out for the trading narrative. In February 2025, LYB ceased business operations at its Houston refinery, with refining treated as a discontinued operation. Separately, in 2025 the company agreed to sell select European olefins and polyolefins assets in France, Germany, the U.K., and Spain, expected to close in the second quarter of 2026; those sites account for roughly 25% of O&P-EAI production capacity. Together, these moves are reshaping the revenue footprint and could remove both low-return capacity and earnings volatility from the portfolio.

Macro & geopolitical exposure

As a specialty chemicals and petrochemicals company, LYB sits at the intersection of hydrocarbon feedstock prices, global trade flows, and energy markets. Its largest exposures are the prices of oil, natural gas liquids, and refined products, because these determine both input costs and regional cost competitiveness. A wide spread between U.S. natural gas and global oil prices, for example, historically benefits North American olefins producers relative to European naphtha-based competitors.

Currency matters too: LYB books revenue and earnings across the Americas, Europe, Asia, and International segments, so dollar strength can compress translated overseas results. Trade policy, including tariffs on chemicals and plastics and export restrictions on feedstocks, can shift where product flows and at what margin. Environmental regulation—especially in Europe, where the asset divestiture is concentrated and where circular-economy rules are tightening—affects both operating permits and long-term demand for recycled content. Because the sector is cyclical and tied to industrial production, LYB also faces end-market demand risk from construction, automotive, packaging, and consumer durables. These are not speculative exposures; they are the standard macro channels through which a global petrochemical company passes revenue and margin.

Recent developments

Recent headlines surrounding LyondellBasell have centered on valuation, turnaround potential, and institutional positioning. On September 2, 2026, Seeking Alpha published “LyondellBasell: The Market Ignores A Massive Earnings Recovery.” A week earlier, on August 25, 2026, Seeking Alpha ran “LyondellBasell: Less Generous And Smaller, But In A Better State Now (Rating Upgrade).” These titles signal a narrative shift: analysts are weighing portfolio shrinkage against improved fundamental health.

On the institutional side, a Defense World headline dated August 26, 2026 noted that Bank of New York Mellon Corp holds an $86.17 million stock position in LyondellBasell. Separately, GuruFocus on August 24, 2026 observed that after a 3.5% decline, LYB traded at $65.20 versus a GF Value estimate of $73.10. (Current snapshot data now puts price at $63.525.) News of this type does not change the company’s operations, but it frames the debate around whether the stock adequately discounts the ongoing restructuring and a potential earnings recovery.

Earnings behavior & post-earnings drift

LYB’s recent earnings record is a useful study in how headline beats can mislead short-term traders. Over the last eight reported quarters, the company beat consensus exactly half the time—4 of 8 reports—with an average earnings surprise of -28.6%. That negative average surprise means misses have, on balance, been larger than beats have been positive. The average 5-day post-earnings drift across those quarters was -0.8%, classified as a down drift. Those are the baseline numbers any trader should keep in mind heading into the next report.

The last four quarters are especially revealing. On July 31, 2026, LYB reported EPS of $4.30 against an estimate of $3.44, a 25% beat, yet the stock fell 2.35% the next day and was down 4.01% five sessions later. The May 1, 2026 report was a much larger surprise—$0.49 actual versus $0.2806 estimated, a 74.6% beat—but the next-day gain was only 1.4%, with the stock sliding 4.31% over the following week. By contrast, the January 30, 2026 miss was dramatic: EPS came in at -$0.26 versus a +$0.1113 consensus, a -333.6% surprise, and the stock nonetheless rose 2.55% the next day and 12.45% over the next five days.

The October 31, 2025 quarter fits the same contradictory pattern: a 24.5% beat on $1.01 versus $0.811 produced a -0.32% next-day move and a -7.32% five-day drift. In other words, even on beat quarters, the post-earnings drift has not reliably continued in the direction of the surprise. This disconnect matters because it tells a trader that the market’s real expectation may be embedded in guidance, commentary on the European divestiture, refining discontinuation, or segment margin trajectory—not simply in whether the EPS line clears a published number.

Looking ahead, LyondellBasell is scheduled to report on October 30, 2026 before the open, with a consensus EPS estimate of $2.80. The current price is $63.525, with an RSI of 50.0 and the 50-day EMA near $63.10, placing the stock roughly neutral on a short-term momentum basis as the report approaches.

Frequently Asked Questions

What does LyondellBasell actually do?

LybondellBasell is a global chemical company that converts liquid and gaseous hydrocarbon feedstocks into plastic resins and other chemicals. It also licenses chemical and polyolefin process technologies, sells polyolefin catalysts, and operates five reportable segments: Olefins and Polyolefins–Americas; Olefins and Polyolefins–Europe, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; and Technology.

Why is LYB’s P/E ratio negative?

The trailing P/E is -56.7 because LyondellBasell’s net margin is currently negative, at -1.1%, with ROE at -3.4%. A negative P/E simply means the company did not generate positive trailing net income, so the traditional price-to-earnings multiple is not meaningful as a standalone valuation gauge.

How has LYB stock typically behaved after earnings?

Over the last eight quarters, LYB beat estimates 50% of the time with an average surprise of -28.6% and an average 5-day post-earnings drift of -0.8% (down). Notably, even strong beats in May and July 2026 were followed by declines over the next week, suggesting the market often reacts more to forward guidance and restructuring progress than to the headline EPS beat.

For a deeper dive into the institutional bull-and-bear case, forward estimate revisions, and sector-relative ratings, readers can review the full institutional verdict on LyondellBasell.

Real Data - Gamma QC Earnings IntelligenceAs of Sep 7, 2026
LyondellBasell Industries N.V. · Basic Materials / Chemicals - Specialty
$20.5BMarket cap
-56.7P/E
-1.1%Net margin
-3.4%ROE
50%Beat rate, last 8Q
-28.6%Avg EPS surprise
-0.8%Avg 5-day move after earnings
2026-10-30Next earnings
ReportedActualEstimateSurprise1D Move5D Move
2026-07-31$4.3$3.44+25%-2.35%-4.01%
2026-05-01$0.49$0.2806+74.6%+1.4%-4.31%
2026-01-30$-0.26$0.1113-333.6%+2.55%+12.45%
2025-10-31$1.01$0.811+24.5%-0.32%-7.32%
2025-08-01$0.62$0.805-23%--
2025-04-25$0.54$0.36+50%--

Previous LYB editions

Beyond the primer

Get the institutional verdict on LYB

Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.

Read the LYB verdict at Gamma QC
$49 Pro / $249 RIA * gammaqc.com

Verify authenticity

Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.